1xbet
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
1xbet-1xir.com
betforward
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
betforward.com.co
yasbetir1.xyz
winbet-bet.com
1kickbet1.com
1xbet-ir1.xyz
hattrickbet1.com
4shart.com
manotobet.net
hazaratir.com
takbetir2.xyz
1betcart.com
betforwardperir.xyz
betforward-shart.com
betforward.com.co
betforward.help
betfa.cam
2betboro.com
1xbete.org
1xbett.bet
romabet.cam
megapari.cam
mahbet.cam
1xbetgiris.cam
betwiner.org
betwiner.org
1xbetgiris.cam
1xbet
1xbet
alvinbet.site
alvinbet.bet
alvinbet.help
alvinbet.site
alvinbet.bet
alvinbet.help
1xbet giris
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
1xbetgiris.cam
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
pinbahis.com.co
betwinner
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
betwiner.org
1xbet
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
1xbete.org
betforward
betforward
betforward
betforward
betforward
betforward
betforward
betforward
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
betforward
betforward
betforward
betforward
betforward
betforward
betforward
betforward
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
yasbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1xbet
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
1betcart.com
betcart
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی
بهترین سایت شرط بندی ایرانی

Global Statistics

All countries
695,781,740
Confirmed
Updated on September 26, 2023 9:04 pm
All countries
627,110,498
Recovered
Updated on September 26, 2023 9:04 pm
All countries
6,919,573
Deaths
Updated on September 26, 2023 9:04 pm

Global Statistics

All countries
695,781,740
Confirmed
Updated on September 26, 2023 9:04 pm
All countries
627,110,498
Recovered
Updated on September 26, 2023 9:04 pm
All countries
6,919,573
Deaths
Updated on September 26, 2023 9:04 pm

Malema accuses Ramaphosa of putting profits before people | News24

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f

Even As a Wicker Man, Alexander Skarsgård’s Got Game. This Scent Will Give You Some Too.

3 min read IF ANYONE CAN MAKE RATTAN hot, it’s Alexander Skarsgård. The actor’s latest film project, about a craftsman who creates a wicker husband (Skarsgård) for a lonely woman (played by Olivia Colman), has been an unlikely hit since its release in theaters last week. But basket weave isn’t the only material Skarsgård’s rocking—he’s

Data Center Health Worries Animate Midterm Campaigns

PAGE, Ariz. — Doug Herrera still lives in the house his father built, though his dad died some time ago from cancer. Herrera wonders if that illness could have been linked to pollutants from nearby uranium mining. Now, he worries that a possible new neighbor — a proposed $10 billion mega data center — could

EFF leader Julius Malema.

EFF leader Julius Malema.

Gallo Images/Jeffrey Abrahams

  • EFF leader Julius Malema says the easing of lockdown restrictions is a clear indication that President Cyril Ramaphosa is chasing profits. 
  • Ramaphosa says all decisions around the lockdown are backed by science.
  • The president says the lockdown was meant to slow the rate of infection and community transmission.

EFF leader Julius Malema has accused President Cyril Ramaphosa of putting profits before lives by easing Covid-19 lockdown restrictions.

Ramaphosa gave oral replies to questions in a virtual sitting of the National Assembly on Thursday afternoon.

Malema asked Ramaphosa whether his decision to ease the lockdown, from alert Level 5 to 4 and then 3, within a short space of time, was informed by scientific evidence.

Ramaphosa responded: “Our response to the coronavirus pandemic has been informed by the advice of our scientists, made up of members of the advisory committee. There are 51 scientists of various diverse disciplines.

READ | Hairdressers and restaurants: Here are all the businesses that will reopen

“It has also been underpinned by experiences of other countries and the guidance we have received from bodies like the World Health Organisation (WHO) and the Africa Centre for Diseases Control and Prevention.

“Through the course of the pandemic, the committee assisted us. Government was guided by the views of scientists. It also considered the economic and social disruption that have been caused by the lockdown.”

Ramaphosa announced on Wednesday night that, under advanced Level 3, restrictions will be eased further, with cinemas, hairdressers, casinos and restaurants allowed to operate again.

In his question, Malema said the scientific-based recommendation by the WHO advised that the number of infections must be visibly declining before lockdowns should be eased.

He wanted to know how Ramaphosa came to the decision to ease restrictions, given the advice of the WHO.

Ramaphosa said: “The committee noted that some of the WHO criteria may not be proper for South Africa. Unlike several other countries, South Africa deliberately implemented a lockdown early in the progression of the disease in a strategy to delay transmission.

READ MORE | Mixed views from opposition parties as Ramaphosa opens more sectors of the economy

“We did this knowing that we will not be able to bring transmissions under control by the time we had to, to ease the lockdown. It would give us the time that we needed to strengthen our health system.”

But Malema did not accept Ramaphosa’s answers.

Malema said: “We are more than convinced that we are not following any scientific advice. You are following business to maximise profits all the time. You are sitting comfortably in your home and you tell children to go to school. Do you have any advice how many people are going to die of this pandemic?

“Or are we just going about as usual with no anticipating of what are the expected infections and deaths within a particular time. You are chasing only profits.”

He said: 

You have a history of sacrificing life in Marikana for profits. We are experiencing it again, where the lives of children are placed at risk.

Julius Malema, EFF

Malema said science would, for instance, not recommend the sale of alcohol.

“There is no science that says, sell alcohol… it is safe to sell alcohol. Science will advise you that, once you sell alcohol, the trauma units will be full and then we will have to divide resources,” he said.

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f

Related Articles

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment

Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Here’s What Congress Might Do on Healthcare After the Midterms

You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f